# Drug Regulation

Protecting the Lab: China Solidifies Drug Data Protection in Historic Regulatory Overhaul

China has implemented a major revision to its drug administration laws, introducing a tiered system that protects clinical trial data for up to six years. This reform aims to incentivize high-end pharmaceutical innovation and align China's intellectual property regime with global standards.